Advertisement

NormOxys Inc., a small-molecule therapeutics firm in Wellesley, has taken in $1.5 million of a debt financing planned to reach almost $1.7 million, per regulatory documents  filed Thursday with the U.S. Securities and Exchange Commission.

In May, the company raised $17.5 million in a Series B round of financing, led by Care Capital LLC, and with participation from existing investor Index Ventures of Switzerland.

SOURCE

Advertisement
Advertisement